T0	Outcomes 379 446	bioavailability of diflunisal-naproxen fixed-dose combination (FDC)
T1	Outcomes 539 566	dissolution behavior of FDC
T2	Outcomes 1058 1081	diflunisal and naproxen
T3	Outcomes 1172 1213	Cmax, AUC0-t, AUC0-∞, tmax, and t1/2 were
T4	Outcomes 1335 1362	of Cmax, AUC0-t, and AUCt-∞